%I WILEY %J ARTHRITIS & RHEUMATOLOGY %L discovery10090942 %V 71 %K Animal models, PPAR and Pulmonary hypertension, Systemic sclerosis %C Atlanta, GA, USA %D 2019 %O This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions. %T The PPAR Agonist Lanifibranor Protects Against Right Ventricular Hypertrophy in a Mouse Model of Systemic Sclerosis Associated Pulmonary Hypertension %A E Derrett-Smith %A K Clark %A S Xu %A D Abraham %A O Lacombe %A P Broqua %A J-L Junien %A I Konstantinova %A C Denton